Cargando…

Iron overload during the treatment of acute leukemia: pretransplant transfusion experience

BACKGROUND: Recent studies have shown the increased risk of mortality in cases with acute leukemia and iron overload. We aimed to determine the status of iron overload in patients with acute leukemia. MATERIALS & METHODS: Patients diagnosed with acute lymphoblastic leukemia (ALL) and acute myelo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yokus, Osman, Herek, Celalettin, Cinli, Tahir Alper, Goze, Hasan, Serin, Istemi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609998/ https://www.ncbi.nlm.nih.gov/pubmed/34840721 http://dx.doi.org/10.2217/ijh-2021-0005

Ejemplares similares

PB1752: SAMATYA-PREDICTING SCORE IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): COMBINING CLINICAL FEATURES WITH FLOW CYTOMETRY
por: Cinli, Tahir Alper, et al.
Publicado: (2023)

A new approach in acute myeloid leukemia (AML): Samatya-predicting score
por: Serin, Istemi, et al.
Publicado: (2022)

Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience
por: Serin, Istemi, et al.
Publicado: (2022)

A Huge Mass in the Liver: Plasmacytoma
por: Cinli, Tahir Alper, et al.
Publicado: (2022)

Secondary Immunodeficiency Frequency in Patients with Chronic Lymphocytic Leukemia: The Relationship with Stage and Treatment
por: Yokus, Osman, et al.
Publicado: (2022)

Prognostic Role of Lymphocyte/Monocyte Ratio in Chronic Lymphocytic Leukemia
por: Yokus, Osman, et al.
Publicado: (2020)

A case report: paroxysmal nocturnal hemoglobinuria and systemic lupus erythematosus association
por: Serin, Istemi, et al.
Publicado: (2020)

PB1841: A NEW APPROACH IN ACUTE MYELOID LEUKEMIA (AML): SAMATYA-PREDICTING SCORE
por: Serin, I., et al.
Publicado: (2022)

PB2075: HOW EFFECTIVE ARE LEPTIN GENE POLYMORPHISMS AND METHYLATION DURING THE COURSE OF MULTIPLE MYELOMA (MM)?
por: Serin, Istemi, et al.
Publicado: (2023)

PB2237: NON-THROMBOTIC INCREASED PORTAL VENOUS PRESSURE IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: IS IT JUST A HYPOTHESIS?
por: Yokus, Osman, et al.
Publicado: (2023)

PB2234: EFFECT OF HYDROXYUREA ON INFLAMMATORY MARKERS IN PATIENTS WITH BCR-ABL NEGATIVE MYELOPROLIFERATIVE DISEASES
por: Altunok, Oguz, et al.
Publicado: (2023)

PB2321: THE EFFECT OF PRE-TREATMENT SERUM KINDLIN-3 ON HODGKIN AND NON-HODGKIN LYMPHOMAS: A SINGLE CENTER EXPERIENCE
por: Keskin, Melike, et al.
Publicado: (2023)

PB2400: THE EFFECT OF BONE MARROW CD4/CD8+ RATIO ON RESPONSE TO TREATMENT AND SURVIVAL IN LYMPHOMAS
por: Can Cavdar, Vahit, et al.
Publicado: (2023)

PB2334: CENTRAL NERVOUS SYSTEM (CNS) RELAPSE IN DIFFUSE LARGE B-CELL LYMPHOMA: CNS-SAMATYA RISK MODEL
por: Yokus, Osman, et al.
Publicado: (2023)

PB2245: POLYCYTHEMIA VERA (PV) AND SECONDARY POLYCYTHEMIA (SP): ARE METABOLIC DIFFERENCES JUST THEORIES?
por: Yokus, Osman, et al.
Publicado: (2023)

Iron Overload in Transfusion-Dependent Indonesian Thalassemic Patients
por: Fianza, Pandji Irani, et al.
Publicado: (2021)

Korean Guideline for Iron Chelation Therapy in Transfusion-Induced Iron Overload
por: Jang, Jun Ho, et al.
Publicado: (2013)

Treating iron overload in patients with non-transfusion-dependent thalassemia
por: Taher, Ali T, et al.
Publicado: (2013)

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2017)

Iron overload across the spectrum of non‐transfusion‐dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions
por: Porter, John B., et al.
Publicado: (2016)

Secondary hemochromatosis as a result of acute transfusion-induced iron overload in a burn patient
por: Amatto, Michael, et al.
Publicado: (2016)

Iron overload status in patients with non-transfusion-dependent thalassemia in China
por: Huang, Yumei, et al.
Publicado: (2022)

The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia
por: Weber, Sarah, et al.
Publicado: (2021)

Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable?
por: Serin, Istemi, et al.
Publicado: (2022)

Clinical outcomes of transfusion-associated iron overload in patients with refractory chronic anemia
por: Gao, Chong, et al.
Publicado: (2014)

Pulmonary function in patients with transfusion-dependent thalassemia and its associations with iron overload
por: Chan, Kate C., et al.
Publicado: (2023)

Transfusion associated circulatory overload
por: Agnihotri, Naveen, et al.
Publicado: (2014)

Exjade® (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion
por: Cappellini, Maria Domenica
Publicado: (2007)

A European survey on the detection and management of iron overload in transfusion-dependent patients with MDS
por: Giagounidis, Aristoteles, et al.
Publicado: (2011)

Type 1 Brugada phenotype induced by cardiac iron overload after blood transfusion
por: Sun, Xue-Rong, et al.
Publicado: (2019)

Educational Case: Transfusion reactions: Transfusion associated circulatory overload vs transfusion-related acute lung injury
por: Desai, Diana S., et al.
Publicado: (2022)

Combination Iron Chelation Therapy with Deferiprone and Deferasirox in Iron-Overloaded Patients with Transfusion-Dependent β-Thalassemia Major
por: Karami, Hossein, et al.
Publicado: (2017)

Safety and Efficacy of the New Combination Iron Chelation Regimens in Patients with Transfusion-Dependent Thalassemia and Severe Iron Overload
por: Origa, Raffaella, et al.
Publicado: (2022)

The impact of iron overload in patients with acute leukemia and myelodysplastic syndrome on hepatic and endocrine functions
por: Yassin, Mohamed A, et al.
Publicado: (2018)

Chronicle of Hypoxemia: Transfusion-Associated Circulatory Overload Versus Transfusion-Related Acute Lung Injury
por: Jha, Shikha, et al.
Publicado: (2022)

The effects of secondary iron overload and iron chelation on a radiation-induced acute myeloid leukemia mouse model
por: Chan, Lap Shu Alan, et al.
Publicado: (2021)

Comment on: “Transfusion associated circulatory overload”
por: Ho, James K. H., et al.
Publicado: (2014)

Gilteritinib (XOSPATA®) in Turkey: Early Access Program Results
por: Dogu, Mehmet Hilmi, et al.
Publicado: (2023)

PB1897: GILTERITINIB IN TURKEY: EARLY ACCESS PROGRAM RESULTS
por: Dogu, Mehmet Hilmi, et al.
Publicado: (2023)

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome
por: de Montalembert, Mariane, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_snkoo4habe4kj1gg9enenf8ip1